Pharmacy News: HCPC Expands Annual Event to Drive Pharma Collaboration
HCPC Expands Annual Event to Drive Pharma Collaboration
The nagging problem of patient adherence to their medicines will be addressed in a novel way at a May event that seeks to bring pharmaceutical industry stakeholders together to review the latest research and collaborate on strategies to improve patient adherence. With RxAdherence 2011, the Healthcare Compliance Packaging Council seeks to foster greater collaboration between marketers and packagers to build a compliance-packaging strategy into the product development and launch process.
For the last 18 years, the Healthcare Compliance Packaging Council (HCPC) has explored the scope of the problem and potential packaging solutions at its annual National Symposium on Patient Compliance. Now HCPC is expanding its lineup of speakers and invited attendees to include pharmaceutical marketing professionals and others involved in pharmaceutical development, branding, and market analysis.
Speakers at the conference will include Vernon Schabert, principal, IMS Health Economics and Outcomes Research, who will review current adherence interventions; Rebecca Burkholder, JD, VP of health policy, National Consumers League, who will explain NCL’s national multi-media campaign; and Tom Hubbard, senior program director, the National Network for Health Innovation, who will look at the current state of adherence programs in the context of ongoing health care reform initiatives.
Data from cases in which packaging has played a role in medication adherence will also be shared. Ted Lithgow, Ph.D., chief science officer, MWV Healthcare, will present just-released peer-reviewed pharmacoepidemiological research analyzing pharmacy claims data. Another presentation, by Kamal Jethwani M.D., lead research Scientist, Center for Connected Health, will review a six-month study on the use of an electronic compliance reminder by patients taking an antihypertensive medication.
Industry peers will come together for a panel discussion in the afternoon on how consumer research, brand marketing, and well-developed compliance prompting packaging brought together early in the process can increase patient refill rate and patient adherence. Featured panelists include Christine Coyne, product director, Endo Pharmaceuticals; Diane Krusko, cardiovascular marketing director, Pfizer; Sander Flaum, CEO, Flaum Partners; Jay Carter, AbelsonTaylor; Justin Schroeder, director, marketing & business development, Anderson Packaging Inc.; and Ted Lithgow, Ph.D., chief science officer, MWV Healthcare. The discussion will be moderated by Christiane Truelove, editor-in-chief, Med Ad News, and Daphne Allen, editor, Pharmaceutical & Medical Packaging News. Both brands are published by UBM Canon.
Hgh canada pharmacy
Continuing a long-standing tradition, Walter Berghahn, executive director, HCPC, will present HCPC’s Compliance Package of the Year Awards Presentation during lunch. (For more details on the competition, visit www.hcpconline.org.)
The event is sponsored by UBM Canon: Pharmaceutical & Medical Packaging News, Med Ad News, PharmaLive.com, and Pharmalot.
About UBM Canon
UBM Canon, the leading B-to-B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging.
Managed Health Care Associates, Inc. (MHA) Released Results of Fourth Annual Independent Long Term Care Member Study with Highlights of Specialty Pharmaceutical Product Utilization
Managed Health Care Associates, Inc. (MHA), a leading health care service company focused on alternate site health care providers, announced the completion of its fourth annual Independent Long Term Care Member Study, the results of which were released at the 2011 MHA Long Term Care Business Summit, March 17, 2011 in Las Vegas, Nevada.
This study was first introduced in 2008 to provide MHA members and other industry stakeholders with additional insight into the operations of independent long term care pharmacies nationwide. Report findings represent participant data in demographic, financial and technology categories as well as by number of residents serviced and geographic region.
New to the 2011 LTC member survey is an analysis highlighting the growing utilization of specialty pharmaceutical products in the long term care setting. These results indicate double digit growth in prescription product utilization of specialty medications used to treat Multiple Sclerosis (MS) and Inflammatory Conditions over a comparative time period of 2009 vs. 2010. The data also demonstrates that long term care pharmacies are increasingly providing specialty pharmaceuticals to seniors across the continuum of care.
“We are pleased to have expanded the scope of this year’s study with dispensing data participation from nearly 900 independent LTC pharmacies nationwide as well as added report topics including Specialty Pharmacy,” stated Michelle Templin, Vice President of Long Term Care. “Our members recognize MHA’s commitment to the LTC industry and to the success of their respective pharmacy operations. And, as the market leader in LTC Pharmacy, we know what it takes to deliver a very meaningful LTC research report.”
MHA members who attended the Business Summit were given a complimentary copy of the Independent Long Term Care Member Study. Members not in attendance will receive a copy of the study directly through their Account Management team. Other interested parties may request copies by contacting MHA’s marketing department.
About MHA
Managed Health Care Associates, Inc. (MHA) is a leading health care service company that offers a growing portfolio of services and solutions to support the diverse and complex needs of the alternate site health care provider. MHA provides expertise in Group Purchasing, Managed Care and Payer Contracting, Reimbursement Management, Specialty Pharmacy Solutions, Pharmaceutical Data Analytics, Clinical Pharmacy Software and Legislative Advocacy. Through the delivery of innovative and targeted health care services and solutions, MHA helps members increase operational efficiency, maximize business growth and provide optimum care for patients.
NCPDP Releases Enhancements to Its Telecommunication, Manufacturer Rebate and Formulary and Benefit Standards
The National Council for Prescription Drug Programs (NCPDP), the leading not-for-profit pharmacy standards development organization, announced today the availability of enhancements to its Telecommunication, Manufacturer Rebate and Formulary and Benefit Standards. Every year billions of pharmacy claims are formatted using NCPDP Standards, the core framework on which the pharmacy industry operates. NCPDP’s Standards provide a uniform format and layout for electronic communication of pharmacy-related data to automate and improve real-time transmission, accuracy, processing and exchange of data. The development of new standards and enhancements to existing standards are conducted using the organization’s collaborative and consensus-building process.
Telecommunication Standard
The Telecommunication Standard defines the record layout for real-time prescription claim transactions, billing pharmacy transactions, certifying eligibility and prescription drug benefits,communicating detailed information defining reimbursement or denial of compensation with explanations, and concurrent drug use review. Enhancements available in the Telecommunication Standard Implementation Guide Version D.6 include:
New field for Controlled Substance Reporting to indicate the prescription was dispensed for use on something other than human.
A means for the pharmacy to submit Section 340B status subsequent to providing the prescription service.
Manufacturer Rebate Standard
The Manufacturer Rebate Standard provides a standardized format for the electronic submission of product utilization, plan membership, formulary information, market definitions, and reconciliation from Pharmacy Management Organizations (PMOs) to Pharmaceutical Industry Contracting Organizations (PICOs).The Manufacturer Rebate Utilization, Plan, Formulary, Market Basket, and Reconciliation Flat File Standard Implementation Guide Version Ø5.ØØ includes editorial corrections to the standard and the removal of fields not in use.
Formulary and Benefit Standard
The Formulary and Benefit Standard provides a standard means for pharmacy benefit payers (including health plans and pharmacy benefit managers) to communicate formulary and benefit information to prescribers via technology vendor systems. Enhancements available in the Formulary and Benefit Standard Implementation Guide Version 3.Ø include:
New field for co-pay specific messaging
Removal of outdated or not used data elements and values
Provides clarity as to the ability for payers to send multiple Quantity Limits (QLS), Text Messages (TMS) and/or Resource Links (RLS)
Consistent support of RxNorm codes
Provides clarity to Formulary Status values
About NCPDP
Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with over 1,600 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for e-Prescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data services include the NCPDP Provider Identification Number, a unique identifier of over 75,000 pharmacies, and HCIdea, “The Prescriber Identity Solution.” NCPDP’s RxReconn™ is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity.